Cremicort to the indication of H-1% include the various forms of acute, subacute and chronic inflammatory, allergic and skin conditions prurigineuse such as neurodermatitis, seborrhoeïsche and atopic dermatitis, contact dermatitis and eczema.
R. / Hydrocortisone. 10 mg - cetomacrogol. 1000 - Cera emul. - Alcoh. cetostearyl. - Paraff. liq. - Vaselin - Propylenglycol. - Kalii sorbate. - Ac. sorbic - Phenoxyaethanol. - Dinatr. edetate. - Aq. Purif. q.s. ad 1 g.
Posology and method of use:
twice a day cream to make the injury and massage until the cream has penetrated into the skin.
Per week more than the contents of one tube (20 grams) installation.
This is a medicine, no prolonged use without medical advice, keep away from children, reading the package insert. Ask your doctor or pharmacist. In case of side effects, contact your doctor.
Herpes simplex, varicella and zona.
Bacterial, viral and fungal infections.
Allergy to active ingredient or the excipients.
atrophy, acne vulgaris and rosacea.
ulcer and wounds.
not apply on the eyelids or mucous membranes.
A systemic effects may occur, particularly in patients on prolonged treatment with topical corticosteroids and used of an occlusion. This effect can manifest by adrenal insufficiency, growth retardation in children and adolescents, a reduction in bone density, cataract and glaucoma. It is therefore important to use the lowest dose that allows a control of symptoms.
If local irritation occurs, treatment should be discontinued.
The clinical picture may be distorted if Cremicort H-1% wrongly is applied to a bacterial, viral or fungal disease. If an infection is present, a modified anti-fungal or antibacterial agent used. If one does not perceive an improvement soon, we will use H-1% Cremicort postpone until the infection is gone.
If the cream is wrongly applied to wounds or infections, may exacerbation or delayed cicatrisatie observed.
Because treatment with corticosteroids there is no causal therapy is the return of disease after discontinuation of therapy possible.
Pregnancy and lactation:
The use of topical corticosteroids should generally be recommended during pregnancy.
There are no known adverse effects when using topical corticosteroids in women at the course of pregnancy, their safety in pregnant women is not proven. In animals, exposure to corticosteroids for topical use resulted in an increased frequency of anomalies in the fetus, even at low doses. Accordingly, using best avoided in pregnant women, particularly at high doses over a long period or in an occlusion.
During lactation, the use of Cremicort-H 1% to be followed.
During extended operation in the face, in the large folds in the anogenital region and skin atrophy may occur, often with irreversible thinning of the skin, telangiectasias and purpura.
Rebound effect, which can lead to dependence on corticosteroids.
delay the wound healing process.
burning sensation, pruritus, irritation, dryness, folliculitis, acneiform eruption, secondary infection .
Contact dermatitis is the cream in very rare cases.
perioral dermatitis, depigmentation or hypertrichosis are rarely observed.
Although a low absorption through the skin, systemic adverse effects are rare. Inhibition of the hypothalamic-pituitary-adrenal axis may occur as a result of the huidresorptie. Certain factors may increase the absorption: application to large areas, use of an occlusion, inflammation of the skin, high concentrations. Infants and small children are more sensitive than adults: effects include Cushing's syndrome and growth retardation. Reduction of bone density, cataract and glaucoma may also occur.
Prolonged treatment with topical corticosteroid preparations should be avoided, especially in young children or children who are sensitive to suppression of adrenal function or the occurrence of Cushing's symptoms.
|Type of product||Medicine|